Common use of Exclusive Field Clause in Contracts

Exclusive Field. Until the completion of all royalty payments under Section 4.5, Enumeral hereby covenants and agrees it shall not practice in the Exclusive Field. For avoidance of any doubt, during such period of time, Enumeral shall not conduct any research or development efforts in the Exclusive Field and shall not file any patent applications claiming any invention in the Exclusive Field or assist Third Parties in doing so. Enumeral further shall not out-license any Enumeral IP for use in the Exclusive Field to any party other than Pieris and shall, if applicable, include in any out-license or other agreement a restriction prohibiting the use of a First Antibody and/or Subsequent Antibody in the Exclusive Field. Enumeral shall remain responsible for enforcement of this Section and shall by liable for any breach of this Section by any licensee or sublicensee of Enumeral that violate this Section. Notwithstanding the foregoing, nothing herein shall be deemed to prevent any Third Party from acquiring Enumeral, even if it is engaged in the research, development or sale of lipocalins, provided it does not use such lipocalins with any Enumeral IP during the period herein.

Appears in 4 contracts

Samples: License and Transfer Agreement (Pieris Pharmaceuticals, Inc.), License and Transfer Agreement (Enumeral Biomedical Holdings, Inc.), License and Transfer Agreement (Pieris Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Exclusive Field. Until the completion of all royalty payments under Section 4.5, Enumeral hereby covenants and agrees it shall not practice in the Exclusive Field. For avoidance of any doubt, during such period of timeDuring the Royalty Term, Enumeral shall not conduct any research or development efforts activities in the Exclusive Field and shall not Field, file any patent applications claiming any invention in the Exclusive Field Field, or assist any Third Parties Party in doing so. Enumeral further shall not out-license any Enumeral IP to any Affiliate or Third Party for use in the Exclusive Field to any party other than Pieris Field, and shall, if applicable, include in any out-license or other agreement a restriction prohibiting the use of a First Antibody and/or Subsequent Antibody in the Exclusive Field. Enumeral shall remain responsible for enforcement of this Section and shall by be liable for any breach of this Section by any licensee or sublicensee of Enumeral that violate this Section. Notwithstanding the foregoing, nothing herein shall be deemed to prevent any Third Party from acquiring Enumeral, even if it is engaged in the research, development or sale of lipocalins, provided it does not use such lipocalins or lipocalin muteins with the First Antibody, Subsequent Antibody, or portion thereof in any Enumeral IP research or development efforts during the period hereinTerm.

Appears in 2 contracts

Samples: Confidential Treatment Requested (Pieris Pharmaceuticals, Inc.), License and Transfer Agreement (Enumeral Biomedical Holdings, Inc.)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.